GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Total Assets

CardioGenics Holdings (CardioGenics Holdings) Total Assets : $0.56 Mil (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Total Assets?

CardioGenics Holdings's Total Assets for the quarter that ended in Jan. 2016 was $0.56 Mil.

Total Assets is connected with ROA %. CardioGenics Holdings's annualized ROA % for the quarter that ended in Jan. 2016 was -126.58%. Total Assets is also linked to Revenue through Asset Turnover. CardioGenics Holdings's Asset Turnover for the quarter that ended in Jan. 2016 was 0.00.


CardioGenics Holdings Total Assets Historical Data

The historical data trend for CardioGenics Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Total Assets Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 0.38 0.55 0.27 0.23

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.23 0.24 0.23 0.56

CardioGenics Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CardioGenics Holdings's Total Assets for the fiscal year that ended in Oct. 2015 is calculated as

Total Assets=Total Equity (A: Oct. 2015 )+Total Liabilities (A: Oct. 2015 )
=-1.563+1.795
=0.23

CardioGenics Holdings's Total Assets for the quarter that ended in Jan. 2016 is calculated as

Total Assets=Total Equity (Q: Jan. 2016 )+Total Liabilities (Q: Jan. 2016 )
=-1.787+2.345
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings  (OTCPK:CGNH) Total Assets Explanation

Total Assets is connected with ROA %.

CardioGenics Holdings's annualized ROA % for the quarter that ended in Jan. 2016 is

ROA %=Net Income (Q: Jan. 2016 )/( (Total Assets (Q: Oct. 2015 )+Total Assets (Q: Jan. 2016 ))/ count )
=-0.5/( (0.232+0.558)/ 2 )
=-0.5/0.395
=-126.58 %

Note: The Net Income data used here is four times the quarterly (Jan. 2016) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CardioGenics Holdings's Asset Turnover for the quarter that ended in Jan. 2016 is

Asset Turnover
=Revenue (Q: Jan. 2016 )/( (Total Assets (Q: Oct. 2015 )+Total Assets (Q: Jan. 2016 ))/ count )
=0/( (0.232+0.558)/ 2 )
=0/0.395
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CardioGenics Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines